Vosevi savings card: as little as $5 a month with commercial insurance

How to pay the least

Ask for the cash price

Vosevi

We didn’t find one.

Ask your pharmacy for Vosevi’s cash price, and one or two other pharmacies too.
Vosevi’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Support Path Patient Assistance Program. Or call 1-855-769-7284.

See if you qualify

Compare every option

Brand nameVosevi

Authorized genericsofosbuvir, velpatasvir, and voxilaprevir

Regular genericsofosbuvir, velpatasvir, and voxilaprevir

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Vosevi?

The original

–

Brand nameThe maker’s card

Gilead Support Path Co-pay Savings Program

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $5 a month

Or call 1-866-664-5327.

In the maker’s words

“Eligible HCV patients could pay as little as $5 per month.”

From the maker’s offer on gilead.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vosevi itself, from the same company, sold without the brand name, and usually for less. For now Vosevi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Chronic hepatitis C after earlier HCV treatment

What the FDA label says

VOSEVI is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor, and is indicated for the treatment of adult patients with chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have:

genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor.
genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor.
- Additional benefit of VOSEVI over sofosbuvir/velpatasvir was not shown in adults with genotype 1b, 2, 4, 5, or 6 infection previously treated with sofosbuvir without an NS5A inhibitor.

Source: the FDA label for Vosevi (Gilead Sciences, Inc.), July 14, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/vosevi/